Corrigendum: Zinc oxide nanoparticles affect the expression of p53, Ras p21 and JNKs: An ex vivo/in vitro exposure study in respiratory disease patients (Mutagenesis (2015) 30:2 (237-245) DOI: 10.1093/mutage/geu064);Zinc oxide nanoparticles affect the expression of p53, Ras p21 and JNKs: An ex vivo/in vitro exposure study in respiratory disease patients

Mutagenesis

Volumn 30, Issue 2, 2015, Pages 237-245

  Kumar, Ashutosh ^a,b   Najafzadeh, Mojgan ^c   Jacob, Badie K ^d   Dhawan, Alok ^a,e   Anderson, Diana ^c  

^a AHMEDABAD UNIVERSITY   (India)

^b INTEGRAL UNIVERSITY   (India)

^c UNIVERSITY OF BRADFORD   (United Kingdom)

^d BRADFORD ROYAL INFIRMARY   (United Kingdom)

^e CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; ANTINEOPLASTIC AGENT; PROTEIN P21; PROTEIN P53; RAS PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; ZINC OXIDE ENGINEERED NANOPARTICLE; ZINC OXIDE NANOPARTICLE; METAL NANOPARTICLE; TP53 PROTEIN, HUMAN; ZINC OXIDE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTHMA; CANCER THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; HUMAN; IN VITRO STUDY; LUNG CANCER; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VERY ELDERLY; CELL CULTURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG EFFECTS; LUNG TUMOR; LYMPHOCYTE; METABOLISM; RESPIRATORY TRACT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ASTHMA; CELLS, CULTURED; FEMALE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG NEOPLASMS; LYMPHOCYTES; MALE; METAL NANOPARTICLES; MIDDLE AGED; PROTO-ONCOGENE PROTEINS P21(RAS); PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT DISEASES; TUMOR SUPPRESSOR PROTEIN P53; ZINC OXIDE;

EID: 84935126299     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/gey013     Document Type: Erratum

References (42)

1. PEN. Project of the Emerging Nanotechnologies (PEN). Available at PEN http://www.nanotechproject.org/inventories/consumer/browse/products/. (accessed September 2014).
2. Kumari, M., Khan, S. S., Pakrashi, S., Mukherjee, A. and Chandrasekaran, N. (2011) Cytogenetic and genotoxic effects of zinc oxide nanoparticles on root cells of Allium cepa. J. Hazard. Mater., 190, 613-621.
3. Kumar, A., Dhawan, A. and Shanker, R. (2011) The need for novel approaches in ecotoxicity of engineered nanomaterials. J. Biomed. Nano-technol., 7, 79-80.
4. Sharma, V., Kumar, A. and Dhawan, A. (2012) Nanomaterials: Exposure, effects and toxicity assessment. Proc. Natl. Acad. Sci. India Sect. B Biol. Sci. 82, 3-11.
5. Borm, P. J., Robbins, D., Haubold, S., et al. (2006) The potential risks of nanomaterials: a review carried out for ECETOC. Part. Fibre Toxicol., 3, 11.
6. Aitken, R. J., Koopman, P. and Lewis, S. E. (2004) Seeds of concern. Nature, 432, 48-52.
7. Aitken, R.J., Hankin, S.M., Lang Tran, C. et al. (2008) A multidisci-plinary approach to the identifcation of reference materials for engineered nanoparticle toxicology. Nanotoxicology, 2, 71-78.
8. Feliu, N. and Fadeel, B. (2010) Nanotoxicology: no small matter. Nanoscale, 2, 2514-2520.
9. Oberdörster, G., Sharp, Z., Atudorei, V., Elder, A., Gelein, R., Kreyling, W. and Cox, C. (2004) Translocation of inhaled ultrafne particles to the brain. Inhal. Toxicol., 16, 437-445.
10. Oberdörster, E. (2004) Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environ. Health Perspect., 112, 1058-1062.
11. Wardak. A., Gorman, M.E., Swami, N. and Deshpande, S. (2008) Identi-fcation of risks in the life cycle of nanotechnology-based products. J. Ind. Ecol. 12, 435-448.
12. Sharma, V., Anderson, D. and Dhawan, A. (2012) Zinc oxide nanoparticles induce oxidative DNA damage and ROS-triggered mitochondria mediated apoptosis in human liver cells (HepG2). Apoptosis, 17, 852-870.
13. Sharma, V., Shukla, R. K., Saxena, N., Parmar, D., Das, M. and Dhawan, A. (2009) DNA damaging potential of zinc oxide nanoparticles in human epidermal cells. Toxicol. Lett., 185, 211-218.
14. Sharma, V., Singh, P., Pandey, A. K. and Dhawan, A. (2012) Induction of oxidative stress, DNA damage and apoptosis in mouse liver after sub-acute oral exposure to zinc oxide nanoparticles. Mutat. Res., 745, 84-91.
15. Shukla, R. K., Sharma, V., Pandey, A. K., Singh, S., Sultana, S. and Dhawan, A. (2011) ROS-mediated genotoxicity induced by titanium dioxide nano-particles in human epidermal cells. Toxicol. In Vitro, 25, 231-241.
16. Shukla, R. K., Kumar, A., Gurbani, D., Pandey, A. K., Singh, S. and Dha-wan, A. (2013) TiO(2) nanoparticles induce oxidative DNA damage and apoptosis in human liver cells. Nanotoxicology, 7, 48-60.
17. Shukla, R. K., Kumar, A., Pandey, A. K., Singh, S. S. and Dhawan, A. (2011) Titanium dioxide nanoparticles induce oxidative stress-mediated apopto-sis in human keratinocyte cells. J. Biomed. Nanotechnol., 7, 100-101.
18. Osman, I. F., Baumgartner, A., Cemeli, E., Fletcher, J. N. and Anderson, D. (2010) Genotoxicity and cytotoxicity of zinc oxide and titanium dioxide in HEp-2 cells. Nanomedicine (Lond)., 5, 1193-1203.
19. Qi, M. and Elion, E. A. (2005) MAP kinase pathways. J. Cell Sci., 118, 3569-3572.
20. Anderson, D., Hughes, J. A., Cebulska-Wasilewska, A., Nizankowska, E. and Graca, B. (1996) ras oncoproteins in human plasma from lung cancer patients and healthy controls. Mutat. Res., 349, 121-126.
21. Eisenberg, S. and Henis, Y. I. (2008) Interactions of Ras proteins with the plasma membrane and their roles in signaling. Cell. Signal., 20, 31-39.
22. Anderson, D., Hughes, J. A., Cebulska-Wasilewska, A., Nizankowska, E. and Graca, B. (1998) Ras p21 protein levels in human plasma from patients with chronic obstructive pulmonary disease (COPD) compared with lung cancer patients and healthy controls. Mutat. Res., 403, 229-235.
23. Cebulska-Wasilewska, A., Wierzewska, A., Nizankowska, E., Graca, B., Hughes, J. A. and Anderson, D. (1999) Cytogenetic damage and ras p21 oncoprotein levels from patients with chronic obstructive pulmonary disease (COPD), untreated lung cancer and healthy controls. Mutat. Res., 431, 123-131.
24. Reuter, C. W., Morgan, M. A. and Bergmann, L. (2000) Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hemato-logic malignancies? Blood, 96, 1655-1669.
25. Dhawan, A. and Sharma, V. (2010) Toxicity assessment of nanomaterials: methods and challenges. Anal. Bioanal. Chem., 398, 589-605.
26. Kumar, A., Pandey, A. K., Singh, S. S., Shanker, R. and Dhawan, A. (2011) Cellular uptake and mutagenic potential of metal oxide nanoparticles in bacterial cells. Chemosphere, 83, 1124-1132.
27. Kumar, A., Pandey, A. K., Singh, S. S., Shanker, R. and Dhawan, A. (2011) Engineered ZnO and TiO(2) nanoparticles induce oxidative stress and DNA damage leading to reduced viability of Escherichia coli. Free Radic. Biol. Med., 51, 1872-1881.
28. Hamilton, R.F., Buford, M.C., Wood, M.B., Arnone, B., Morandi, M. and Holian, A. (2007) Engineered carbon nanoparticles alter macrophage immune function and initiate airway hyper-responsiveness in the BALB/c mouse model. Nanotoxicology 1, 104-117.
29. Sharma, V., Singh, S. K., Anderson, D., Tobin, D. J. and Dhawan, A. (2011) Zinc oxide nanoparticle induced genotoxicity in primary human epidermal keratinocytes. J. Nanosci. Nanotechnol., 11, 3782-3788.
30. Andersson-Willman, B., Gehrmann, U., Cansu, Z., Buerki-Thurnherr, T., Krug, H. F., Gabrielsson, S. and Scheynius, A. (2012) Effects of subtoxic concentrations of TiO2 and ZnO nanoparticles on human lymphocytes, dendritic cells and exosome production. Toxicol. Appl. Pharmacol., 264, 94-103.
31. Magdolenova, Z., Collins, A., Kumar, A., Dhawan, A., Stone, V. and Dusinska, M. (2014) Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles. Nanotoxicology, 8, 233-278.
32. Kain, J., Karlsson, H. L. and Möller, L. (2012) DNA damage induced by micro-and nanoparticles-interaction with FPG infuences the detection of DNA oxidation in the comet assay. Mutagenesis, 27, 491-500.
33. Meek, D. W. (2009) Tumour suppression by p53: a role for the DNA damage response? Nat. Rev. Cancer, 9, 714-723.
34. Eizenberg, O., Faber-Elman, A., Gottlieb, E., Oren, M., Rotter, V. and Schwartz, M. (1996) p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells. Mol. Cell. Biol., 16, 5178-5185.
35. Gong, X., Liu, A., Ming, X., Deng, P. and Jiang, Y. (2010) UV-induced interaction between p38 MAPK and p53 serves as a molecular switch in determining cell fate. FEBS Lett., 584, 4711-4716.
36. Das, J., Ho, M., Zikherman, J., Govern, C., Yang, M., Weiss, A., Chakraborty, A. K. and Roose, J. P. (2009) Digital signaling and hysteresis characterize ras activation in lymphoid cells. Cell, 136, 337-351.
37. Anderson, D. (2001) Expression of ras (p21) protein in plasma from exposed workers and from patients with lung disease. Int. J. Hyg. Environ. Health, 204, 55-60.
38. Basu, S., Harfouche, R., Soni, S., Chimote, G., Mashelkar, R. A. and Sen-gupta, S. (2009) Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy. Proc. Natl. Acad. Sci. U. S. A., 106, 7957-7961.
39. Kumar, A. and Dhawan, A. (2013) Genotoxic and carcinogenic potential of engineered nanoparticles: an update. Arch. Toxicol., 87, 1883-1900.
40. Kumar, A., Khan, S. and Dhawan, A. (2014) Comprehensive molecular analysis of the responses induced by titanium dioxide nanoparticles in human keratinocyte cells. J. Transl. Toxicol. 1, 28-39.
41. Kumar, A., Pandey, A. K., Singh, S. S., Shanker, R. and Dhawan, A. (2011) Cellular response to metal oxide nanoparticles in bacteria. J. Biomed. Nanotechnol., 7, 102-103.
42. Sharma, V., Anderson, D. and Dhawan, A. (2011) Zinc oxide nanoparticles induce oxidative stress and genotoxicity in human liver cells (HepG2). J. Biomed. Nanotechnol., 7, 98-99.